Commercial Blenderized Tube Feeding Formulas: Recent Evidence Supports Improved Clinical and Health Economic Outcomes
![Katherine H. Bennett Katherine H. Bennett](/sites/default/files/styles/100_100_crope_and_scale/public/2022-08/k._bennett.jpg?itok=0AZAifxx)
![Amarsinh Desai Amarsinh Desai](/sites/default/files/styles/100_100_crope_and_scale/public/2022-08/a.desai_.jpg?itok=RYPHY-aR)
![Aimee Henrikson Aimee Henrikson](/sites/default/files/styles/100_100_crope_and_scale/public/2022-08/aimee_2.jpg?itok=BTY7yAqa)
About this Webinar
Learning Objectives:
1. Explain recently published real world evidence on the clinical and health economic outcomes of utilizing commercially blenderized formulas for tube-fed children and adults.
2. Describe at least two examples of how this recent data will change clinical practice.
3. Apply learnings through a case-based approach to identify how and when to utilize commercially blenderized formulas with tube fed patients.